BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Epigallocatechin gallate induces a hepatospecific decrease in the CYP3A expression level by altering intestinal flora. ✅
Go to Publication ✅
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences (Eur J Pharm Sci ) Vol: 100 Issue Pages: 211-218 Pub: 2017 Mar 30 Epub: 2017 Jan 21 Authors Ikarashi N , Ogawa S , Hirobe R , Kon R , Kusunoki Y , Yamashita M , Mizukami N , Kaneko M , Wakui N , Machida Y , Sugiyama K , |
|
|
Epigallocatechin gallate induces a hepatospecific decrease in the CYP3A expression level by altering intestinal flora. ✅
Go to Publication ✅
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences (Eur J Pharm Sci ) Vol: 100 Issue Pages: 211-218 Pub: 2017 Mar 30 Epub: 2017 Jan 21 Authors Ikarashi N , Ogawa S , Hirobe R , Kon R , Kusunoki Y , Yamashita M , Mizukami N , Kaneko M , Wakui N , Machida Y , Sugiyama K , |
|
|
In Vivo Effects of Tea Polyphenol Intake on Human Intestinal Microflora and Metabolism. ✅
Go to Publication ✅
Bioscience, biotechnology, and biochemistry (Biosci Biotechnol Biochem ) Vol: 56 Issue 4 Pages: 588-91 Pub: 1992 Jan Epub: Authors Okubo T , Ishihara N , Oura A , Serit M , Kim M , Yamamoto T , Mitsuoka T , |
|
|
In Vivo Effects of Tea Polyphenol Intake on Human Intestinal Microflora and Metabolism. ✅
Go to Publication ✅
Bioscience, biotechnology, and biochemistry (Biosci Biotechnol Biochem ) Vol: 56 Issue 4 Pages: 588-91 Pub: 1992 Jan Epub: Authors Okubo T , Ishihara N , Oura A , Serit M , Kim M , Yamamoto T , Mitsuoka T , |
|
|
Raw Bowl Tea (Tuocha) Polyphenol Prevention of Nonalcoholic Fatty Liver Disease by Regulating Intestinal Function in Mice. ✅
Biomolecules (Biomolecules ) Vol: 9 Issue 9 Pages: Pub: 2019 Sep 1 Epub: 2019 Sep 1 Authors Liu B , Zhang J , Sun P , Yi R , Han X , Zhao X , |
|
|
Green tea polyphenol (epigallocatechin-3-gallate) improves gut dysbiosis and serum bile acids dysregulation in high-fat diet-fed mice. ✅
Go to Publication ✅
Journal of clinical biochemistry and nutrition (J Clin Biochem Nutr ) Vol: 65 Issue 1 Pages: 34-46 Pub: 2019 Jul Epub: 2019 Apr 6 Authors Ushiroda C , Naito Y , Takagi T , Uchiyama K , Mizushima K , Higashimura Y , Yasukawa Z , Okubo T , Inoue R , Honda A , Matsuzaki Y , Itoh Y , |
|
|
Tea Polyphenol Epigallocatechin Gallate Protects Against Nonalcoholic Fatty Liver Disease and Associated Endotoxemia in Rats via Modulating Gut Microbiota Dysbiosis and Alleviating Intestinal Barrier Dysfunction and Related Inflammation. ✅
Go to Publication ✅
Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: Issue Pages: Pub: 2024 Apr 12 Epub: 2024 Apr 12 Authors Zuo G , Chen M , Zuo Y , Liu F , Yang Y , Li J , Zhou X , Li M , Huang JA , Liu Z , Lin Y , |
|
|
Epigallocatechin gallate alleviates osteoporosis by regulating the gut microbiota and serum metabolites in rats. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 14 Issue 23 Pages: 10564-10580 Pub: 2023 Nov 27 Epub: 2023 Nov 27 Authors Han X , Fu Y , Wang K , Li S , Jiang C , Wang S , Wang Z , Liu G , Hu S , |
|
|
Liposomal Epigallocatechin-3-Gallate for the Treatment of Intestinal Dysbiosis in Children with Autism Spectrum Disorder: A Comprehensive Review. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 15 Issue 14 Pages: Pub: 2023 Jul 24 Epub: 2023 Jul 24 Authors de la Rubia Ortí JE , Moneti C , Serrano-Ballesteros P , Castellano G , Bayona-Babiloni R , Carriquí-Suárez AB , Motos-Muñoz M , Proaño B , Benlloch M , |
|
|
Tea polyphenol and epigallocatechin gallate ameliorate hyperlipidemia via regulating liver metabolism and remodeling gut microbiota. ✅
Go to Publication ✅
Food chemistry (Food Chem ) Vol: 404 Issue Pt A Pages: 134591 Pub: 2023 Mar 15 Epub: 2022 Oct 14 Authors Wen JJ , Li MZ , Chen CH , Hong T , Yang JR , Huang XJ , Geng F , Hu JL , Nie SP , |
|
|
Epigallocatechin-3-Gallate Decreases Plasma and Urinary Levels of p-Cresol by Modulating Gut Microbiota in Mice. ✅
Go to Publication ✅
ACS omega (ACS Omega ) Vol: 7 Issue 44 Pages: 40034-40041 Pub: 2022 Nov 8 Epub: 2022 Oct 28 Authors Unno T , Ichitani M , |
|
|
Dietary Epigallocatechin-3-Gallate Alters the Gut Microbiota of Obese Diabetic db/db Mice: Lactobacillus Is a Putative Target. ✅
Go to Publication ✅
Journal of medicinal food (J Med Food ) Vol: 23 Issue 10 Pages: 1033-1042 Pub: 2020 Oct Epub: Authors Park JM , Shin Y , Kim SH , Jin M , Choi JJ , |
|
|
Effects of Different Levels of Green Tea Powder on Performance, Antioxidant Activity, Egg Mass, Quality, and Cecal Microflora of Chickens. ✅
Go to Publication ✅
Animals : an open access journal from MDPI (Animals (Basel) ) Vol: 14 Issue 20 Pages: Pub: 2024 Oct 18 Epub: 2024 Oct 18 Authors Luo W , Tan Q , Li H , Ye T , Xiao T , Tian X , Wang W , |
|
|
Green tea leaf powder prevents dyslipidemia in high-fat diet-fed mice by modulating gut microbiota. ✅
Go to Publication ✅
Food & nutrition research (Food Nutr Res ) Vol: 64 Issue Pages: Pub: 2020 Epub: 2020 Nov 13 Authors Wang J , Li P , Liu S , Zhang B , Hu Y , Ma H , Wang S , |
|
|
Green tea extract alters gut microbiota and their metabolism of adults with metabolic syndrome in a host-free human colonic model. ✅
Go to Publication ✅
Food research international (Ottawa, Ont.) (Food Res Int ) Vol: 160 Issue Pages: 111762 Pub: 2022 Oct Epub: 2022 Jul 30 Authors Zhang S , Xu M , Sun X , Shi H , Zhu J , |
|
|
Green tea extract alters gut microbiota and their metabolism of adults with metabolic syndrome in a host-free human colonic model. ✅
Go to Publication ✅
Food research international (Ottawa, Ont.) (Food Res Int ) Vol: 160 Issue Pages: 111762 Pub: 2022 Oct Epub: 2022 Jul 30 Authors Zhang S , Xu M , Sun X , Shi H , Zhu J , |
|
|
Green tea polyphenols boost gut-microbiota-dependent mitochondrial TCA and urea cycles in Sprague-Dawley rats. ✅
Go to Publication ✅
The Journal of nutritional biochemistry (J Nutr Biochem ) Vol: 81 Issue Pages: 108395 Pub: 2020 Jul Epub: 2020 Apr 8 Authors Zhou J , Tang L , Shen CL , Wang JS , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
